Status:

UNKNOWN

HbA1c and Neurocognitive Disorders

Lead Sponsor:

University of Thessaly

Collaborating Sponsors:

University Hospital, Ioannina

Larissa University Hospital

Conditions:

Neurocognitive Disorders

HbA1c

Eligibility:

All Genders

45-80 years

Brief Summary

Preliminary evidence suggest a possible relationship between HbA1c and perioperative neurocognitive disorders (NCD). We are going to investigate whether the preoperative value of HbA1c in patients und...

Detailed Description

It is estimated that approximately 10% of elderly undergoing surgery will develop cognitive changes perioperatively, while in some reports the incidence rises up to 80%. Despite the reported high prev...

Eligibility Criteria

Inclusion

  • 1\) 45 - 80 years
  • 2\) American Society of Anesthesiologists physical status I to III
  • 3\) elective general, urological, gynecological and orthopedic surgery under general anesthesia
  • 4\) native speakers of the Greek language

Exclusion

  • 1\) refused to participate or sign the informed consent form
  • 2\) had undergone surgery or anesthesia within the last 30 days
  • 3\) had any prior or current history involving an affliction of the central nervous system
  • 4\) were diagnosed with severe cognitive decline based on the 16 - item Informant Questionnaire on Cognitive Decline (IQCODE - 16)
  • 5\) suffered from severe hearing or visual impairment
  • 6\) any psychiatric disorder
  • 7\) had a score \>5 in the Geriatric Depression Scale (GDS - 15)
  • 8\) or a score in females \< 4 males \< 2 in the Lawton - Brody Instrumental Activities of Daily Living Scale (I.A.D.L.)
  • 9\) reported alcohol consumption \> 35 units/week
  • 10\) drug dependence
  • 11\) had undergone previous neuropsychological testing
  • 12\) Diabetes Mellitus type II with \> 10 years of diagnosis
  • 13\) Diabetes Mellitus type I
  • 14\) Hemoglobin A1c (HbA1c) \> 7.5%
  • 15\) suffered from hemodynamical instability (\> 20% alterations of blood pressure perioperatively)
  • 16\) or desaturation (one or more events of SpO2 \< 80% for more than 2 minutes) peri-operatively
  • 17\) or blood loss of more than one unit

Key Trial Info

Start Date :

December 1 2015

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 1 2021

Estimated Enrollment :

288 Patients enrolled

Trial Details

Trial ID

NCT04736277

Start Date

December 1 2015

End Date

November 1 2021

Last Update

October 11 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Thessaly

Larissa, Greece, 41335